These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 33196051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
    Taylor A, Jones T, Forehand CC, Smith SE, Dykes H, Newsome AS.
    J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
    [Abstract] [Full Text] [Related]

  • 6. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
    Wu Z, Zhang S, Xu J, Xie J, Huang L, Huang Y, Yang Y, Qiu H.
    Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
    [Abstract] [Full Text] [Related]

  • 7. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.
    Anantasit N, Boyd JH, Walley KR, Russell JA.
    Crit Care Med; 2014 Aug; 42(8):1812-20. PubMed ID: 24919159
    [Abstract] [Full Text] [Related]

  • 8. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
    Xu J, Cai H, Zheng X.
    BMC Infect Dis; 2023 Apr 03; 23(1):199. PubMed ID: 37013474
    [Abstract] [Full Text] [Related]

  • 9. Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial.
    Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, Park CHL, Fukushima JT, Rizk SI, Szeles TF, Dos Santos Neto NC, Filho RK, Galas FRBG, Landoni G.
    Crit Care Med; 2019 Dec 03; 47(12):1743-1750. PubMed ID: 31609774
    [Abstract] [Full Text] [Related]

  • 10. Impact of the Sequence of Norepinephrine and Vasopressin Discontinuation in Patients Recovering From Septic Shock.
    Bredhold BE, Winters SD, Callison JC, Heidel RE, Allen LM, Hamilton LA.
    Hosp Pharm; 2020 Feb 03; 55(1):26-31. PubMed ID: 31983763
    [Abstract] [Full Text] [Related]

  • 11. Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock.
    Brask AL, Shemanski SM, Barnes TE, Holmes AK.
    Ann Pharmacother; 2023 May 03; 57(5):521-526. PubMed ID: 36039490
    [Abstract] [Full Text] [Related]

  • 12. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N, Altshuler D, Merchan C, Zakhary B, Aberle C, Papadopoulos J.
    Ann Pharmacother; 2018 Aug 03; 52(8):733-739. PubMed ID: 29560736
    [Abstract] [Full Text] [Related]

  • 13. Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.
    Cheung WK, Chau LS, Mak II, Wong MY, Wong SL, Tiwari AF.
    Intensive Crit Care Nurs; 2015 Dec 03; 31(6):359-65. PubMed ID: 26292920
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vasopressin Initiation as a Second-Line VasoPressor in Early Septic Shock (VISPSS).
    Ragoonanan D, Nickelsen P, Tran N, Allen B, Emborski R, Legare A, Villela A, Hampson L, Busey K, Shomo E, Broomfield A, Hailu K.
    J Intensive Care Med; 2024 Apr 03; 39(4):306-312. PubMed ID: 37715634
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ, Cadiz ML, Natavio AM.
    Ann Pharmacother; 2020 Mar 03; 54(3):213-218. PubMed ID: 31625395
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST, Shah P, Hollands JM, Shah RA, Shannon WD, Kollef MH.
    Surg Infect (Larchmt); 2007 Apr 03; 8(2):189-200. PubMed ID: 17437364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.